These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Management of stage II seminoma. Warde P; Gospodarowicz M; Panzarella T; Catton C; Sturgeon J; Moore M; Jewett M J Clin Oncol; 1998 Jan; 16(1):290-4. PubMed ID: 9440755 [TBL] [Abstract][Full Text] [Related]
28. Surgical Management of Cervical Non-seminomatous Germ Cell Tumor Metastases. Nwosu OI; Jones AJ; Alwani M; Einhorn LH; Moore MG; Mantravadi AV Laryngoscope; 2021 Jul; 131(7):1528-1534. PubMed ID: 33421136 [TBL] [Abstract][Full Text] [Related]
29. Serum lactate dehydrogenase isoenzyme 1 and relapse in patients with nonseminomatous testicular germ cell tumors clinical stage I. von Eyben FE; Madsen EL; Blaabjerg O; Petersen PH; von der Maase H; Jacobsen GK; Rørth M Acta Oncol; 2001; 40(4):536-40. PubMed ID: 11504315 [TBL] [Abstract][Full Text] [Related]
30. Surveillance in stage I testicular seminoma - risk of late relapse. Chung P; Parker C; Panzarella T; Gospodarowicz MK; Jewett S; Milosevic MF; Catton CN; Bayley AJ; Tew-George B; Moore M; Sturgeon JF; Warde P Can J Urol; 2002 Oct; 9(5):1637-40. PubMed ID: 12431325 [TBL] [Abstract][Full Text] [Related]
31. An analysis of surveillance for stage I combined teratoma--seminoma of the testis. Thomas R; Dearnaley D; Nicholls J; Norman A; Sampson S; Horwich A Br J Cancer; 1996 Jul; 74(1):59-62. PubMed ID: 8679458 [TBL] [Abstract][Full Text] [Related]
32. Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group. Tandstad T; Smaaland R; Solberg A; Bremnes RM; Langberg CW; Laurell A; Stierner UK; Ståhl O; Cavallin-Ståhl EK; Klepp OH; Dahl O; Cohn-Cedermark G J Clin Oncol; 2011 Feb; 29(6):719-25. PubMed ID: 21205748 [TBL] [Abstract][Full Text] [Related]
33. What is the role of enlarged lymph node resection alone in patients with nonseminomatous germ cell tumor who had stage II or III disease? Ekenel M; Keskin S; Sanli Ö; Bavbek S; Tunç M; Ander H; Ozcan F; Kiliçaslan I; Başaran M Clin Genitourin Cancer; 2012 Sep; 10(3):185-9. PubMed ID: 22682983 [TBL] [Abstract][Full Text] [Related]
34. Surgical management of late relapse on surveillance in patients presenting with clinical stage I testicular cancer. Rice KR; Beck SD; Pedrosa JA; Masterson TA; Einhorn LH; Foster RS Urology; 2014 Oct; 84(4):886-90. PubMed ID: 25260450 [TBL] [Abstract][Full Text] [Related]
35. Surveillance alone versus radiotherapy after orchiectomy for clinical stage I nonseminomatous testicular cancer. Danish Testicular Cancer Study Group. Rørth M; Jacobsen GK; von der Maase H; Madsen EL; Nielsen OS; Pedersen M; Schultz H J Clin Oncol; 1991 Sep; 9(9):1543-8. PubMed ID: 1714948 [TBL] [Abstract][Full Text] [Related]
37. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. Warde P; Specht L; Horwich A; Oliver T; Panzarella T; Gospodarowicz M; von der Maase H J Clin Oncol; 2002 Nov; 20(22):4448-52. PubMed ID: 12431967 [TBL] [Abstract][Full Text] [Related]
39. Observation versus adjuvant radiation or chemotherapy in the management of stage I seminoma: clinical outcomes and prognostic factors for relapse in a large US cohort. Soper MS; Hastings JR; Cosmatos HA; Slezak JM; Wang R; Lodin K Am J Clin Oncol; 2014 Aug; 37(4):356-9. PubMed ID: 23275274 [TBL] [Abstract][Full Text] [Related]
40. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion. Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]